FDA to Develop Framework for Continued Expanded Access to Infant Formula

As we previously have reported, in May FDA announced an enforcement discretion policy which would allow certain non-compliant infant formula to be marketed in the U.S. The policy, which will remain in effect until November 14, 2022, was intended to address the infant formula shortage that resulted from the temporary shutdown of Abbot’s facility in... Continue Reading